DGFT removes restrictions on syringe exports

In 2021, the export of syringes stood at $45.68 million. It was $17.37 million during April-July this fiscal

The government has removed restrictions on exports of syringes with immediate effect, according to a notification. Restrictions were imposed last year in the wake of the COVID-19 pandemic.

“The export policy of all kinds of syringes…has been made free with immediate effect,” the Directorate General of Foreign Trade (DGFT) has said in a notification.

In 2021, the export of syringes stood at $45.68 million. It was $17.37 million during April-July this fiscal.

In a separate notification, DGFT said the last date for exporters to submit online applications to claim their pending dues under different export promotion schemes has been extended till 28th February this year.

On 9th September, 2021, the government had announced releasing Rs 56,027 crores against pending tax refunds of exporters under various export incentive schemes.

The last date for claiming pending refunds under the schemes — Merchandise Exports from India Scheme (MEIS), Services Export from India Scheme (SEIS) and Rebate of State and Central Levies and Taxes (RoSCLT) — was earlier fixed as 31st January.

COVID impactDGFTpharma exportssyringe exports
Comments (0)
Add Comment